None listed
Conditions
Interventions
None listed
Sponsors
Yonsei University Health System, Severance Hospital
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1) Age =20 years old 2) Acute ischemic stroke patients who underwent CT angiographies before intravenous thrombolytic treatment 3) Patients who give an informed consents for participation in the study or the legal representative or immediate family give informed consent on behalf of patients in case of difficulty to decide study enrollment.
Exclusion criteria
Exclusion criteria: 1) Age <20 years old 2) Acute ischemic stroke patients who did not receive intravenous thrombolytic treatment 3) No informed consents from patients
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Complications (extracranial life-threatening bleeding, herniation, infection);Recanalization rate;Hemorrhagic transformation;Modified Rankin scale scores at discharge and 3 months ;Death at 6 months and during follow-up;NIHSS(National Institutes of Health Stroke Scale) scores after IV rt-PA(intravenous recombinant tissue plasminogen activator) infusion, at 1 day and discharge | — |
Secondary
| Measure | Time frame |
|---|---|
| Cut-off values in areas of irreversible changes according to non-contrast CT images;Cut-off values in occlusion sites and collateral scores according to CT angiographies; Cut-off values of consolidated CT imaging index;Cut-off values of comorbidity index;Cut-off values in thrombus volume and Hounsfield unit according to non-contrast CT images ;Medical care expenses according to comorbidity index in patients who received intravenous thrombolytic treatment and/or endovascular recanalization treatments; Stroke subtypes ;Clinical informations, laboratory tests;Causes of deaths | — |
Countries
Korea, Republic of
Contacts
Public ContactKim Young
Yonsei University Health System, Severance Hospital
Outcome results
None listed